Literature DB >> 19571153

Parkinson's disease and tea: a quantitative review.

José Luis Barranco Quintana1, Mohamed Farouk Allam, Amparo Serrano Del Castillo, Rafael Fernández-Crehuet Navajas.   

Abstract

PURPOSE: To evaluate the risk of PD associated with tea consumption.
MATERIAL AND METHODS: We reviewed all observational studies that evaluated the association between PD risk and tea consumption. Only, 12 studies were identified: 11 case-control and 1 cohort. These studies were carried out between 1981 and 2003. The studies represented different populations from 3 continents; North America, Europe and Asia. The 3 studies from Asia were case-control studies of Chinese populations.
RESULTS: There was a clear protective effect of tea consumption in the pooled risk estimate [OR: 0.83 (95% confidence interval 0.74 to 0.92)] with 2215 cases and 145578 controls. However, the homogeneity test was significant (p value of 0.008), denoting heterogeneity across the pooled studies. Pooled analysis applying the random effect model was OR: 0.81 with 95% confidence interval nearly overlapping unity (95% confidence interval 0.67 to 0.98). Tea consumers versus non-consumers in Chinese populations had pooled OR of 0.73 with 95% confidence interval 0.60 to 0.90 (470 cases and 623 controls). The p value of homogeneity test was 0.96, denoting homogeneity across the pooled 3 studies.
CONCLUSION: Tea consumption can protect against PD and this protective effect is clearer in Chinese populations. The low rate of tea consumption among persons with PD should provide us many valuable insights into the nature of the illness.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19571153     DOI: 10.1080/07315724.2009.10719754

Source DB:  PubMed          Journal:  J Am Coll Nutr        ISSN: 0731-5724            Impact factor:   3.169


  11 in total

1.  Non-genetic factors associated with the risk of Parkinson's disease in Iranian patients.

Authors:  N Hosseini Tabatabaei; B Babakhani; A Hosseini Tabatabaei; Z Vahabi; A Soltanzadeh
Journal:  Funct Neurol       Date:  2013 Apr-May

Review 2.  Tea and human health: biomedical functions of tea active components and current issues.

Authors:  Zong-mao Chen; Zhi Lin
Journal:  J Zhejiang Univ Sci B       Date:  2015-02       Impact factor: 3.066

Review 3.  Pathophysiological roles for purines: adenosine, caffeine and urate.

Authors:  Micaela Morelli; Anna R Carta; Anil Kachroo; Michael A Schwarzschild
Journal:  Prog Brain Res       Date:  2010       Impact factor: 2.453

4.  Association of Tooth Loss with New-Onset Parkinson's Disease: A Nationwide Population-Based Cohort Study.

Authors:  Ho Geol Woo; Yoonkyung Chang; Ji Sung Lee; Tae-Jin Song
Journal:  Parkinsons Dis       Date:  2020-07-13

5.  A meta-analysis of tea drinking and risk of Parkinson's disease.

Authors:  Feng-Jiao Li; Hong-Fang Ji; Liang Shen
Journal:  ScientificWorldJournal       Date:  2012-02-15

Review 6.  Beneficial Effects of Green Tea Catechins on Neurodegenerative Diseases.

Authors:  Monira Pervin; Keiko Unno; Tomokazu Ohishi; Hiroki Tanabe; Noriyuki Miyoshi; Yoriyuki Nakamura
Journal:  Molecules       Date:  2018-05-29       Impact factor: 4.411

Review 7.  Beneficial Effects of Epigallocatechin-3-O-Gallate, Chlorogenic Acid, Resveratrol, and Curcumin on Neurodegenerative Diseases.

Authors:  Ryuuta Fukutomi; Tomokazu Ohishi; Yu Koyama; Monira Pervin; Yoriyuki Nakamura; Mamoru Isemura
Journal:  Molecules       Date:  2021-01-14       Impact factor: 4.411

Review 8.  Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG).

Authors:  Neha Atulkumar Singh; Abul Kalam Azad Mandal; Zaved Ahmed Khan
Journal:  Nutr J       Date:  2016-06-07       Impact factor: 3.271

Review 9.  Prevention of progression in Parkinson's disease.

Authors:  Jan Aaseth; Petr Dusek; Per M Roos
Journal:  Biometals       Date:  2018-07-20       Impact factor: 2.949

Review 10.  Natural Phytochemicals as Novel Therapeutic Strategies to Prevent and Treat Parkinson's Disease: Current Knowledge and Future Perspectives.

Authors:  Rengasamy Balakrishnan; Shofiul Azam; Duk-Yeon Cho; In Su-Kim; Dong-Kug Choi
Journal:  Oxid Med Cell Longev       Date:  2021-05-25       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.